scholarly journals Cost-Effectiveness Analysis of Indacaterol/Glycopirronium (QVA149) as a Maintenance Bronchodilator Treatment in Adult Patients With Chronic Obstructive Pulmonary Disease in Spain

2014 ◽  
Vol 17 (7) ◽  
pp. A598
Author(s):  
M. Granell ◽  
M. Giovanna ◽  
S. Paz ◽  
I. Betoret
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Cost Effectiveness ◽  
Pulmonary Disease ◽  
Cost Effectiveness Analysis ◽  
Adult Patients ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Effectiveness Analysis ◽  
Bronchodilator Treatment

Evaluating the cost-effectiveness of combination inhalers for the management of chronic obstructive pulmonary disease

2020 ◽  
Vol 26 (9) ◽  
pp. 231-233
Author(s):  
Matthew Taylor ◽  
Michelle Green
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Cost Effectiveness ◽  
Pulmonary Disease ◽  
Cost Effectiveness Analysis ◽  
Chronic Obstructive ◽  
Valuable Insight ◽  
Obstructive Pulmonary Disease ◽  
Effectiveness Analysis ◽  
The Cost ◽  
Insight Into

Matthew Taylor and Michelle Green provide a valuable insight into methods of vital cost-effectiveness analysis of combination inhalers for the management of chronic obstructive pulmonary disease.

Sign in / Sign up

Export Citation Format

Share Document